Estimaciones de analistas de Wall Street para UFP Technologies, Inc. (UFPT): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-11-02 | $2.63 | ||
| 2026-08-03 | $2.69 | $2.31 | +16.5% |
| 2026-05-04 | $2.27 | $2.18 | +4.1% |
| 2026-02-24 | $2.44 | $2.26 | +8.0% |
| 2025-11-03 | $2.39 | $2.22 | +7.7% |
| 2025-08-04 | $2.50 | $2.29 | +9.2% |
| 2025-05-06 | $2.47 | $2.05 | +20.5% |
| 2025-02-25 | $2.46 | $1.98 | +24.2% |
Ratios de valoración
| Ratio P/E | 29.85 |
| Precio / Valor contable | 4.67 |
| EV / EBITDA | 19.84 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $146.1M | $147.8M | $190.5M | $198.4M | $179.4M | $206.3M | $353.8M | $400.1M | $504.4M | $602.8M |
| Coste de Ventas | $111.5M | $112.4M | $142.1M | $144.4M | $134.7M | $155.2M | $263.5M | $287.8M | $357.7M | $432.4M |
| Beneficio Bruto | $34.6M | $35.5M | $48.3M | $54.0M | $44.7M | $51.1M | $90.3M | $112.2M | $146.7M | $170.4M |
| I+D | $1.3M | $1.1M | $10.5M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Generales y Administrativos | $24.1M | $23.8M | $27.8M | $29.3M | $27.5M | $29.5M | $45.8M | $50.9M | $62.2M | $77.4M |
| Gastos Operativos | $24.1M | $23.8M | $27.8M | $29.3M | $28.0M | $29.9M | $34.9M | $54.6M | $65.8M | $78.1M |
| Beneficio Operativo | $12.2M | $11.7M | $19.6M | $24.7M | $16.7M | $21.2M | $55.4M | $57.7M | $80.9M | $92.3M |
| EBITDA | $18.0M | $17.4M | $28.5M | $32.5M | $24.6M | $29.7M | $67.4M | $69.0M | $95.8M | $115.7M |
| Gastos por Intereses | $69000 | $50000 | $1.3M | $674000 | $83000 | $39000 | $2.8M | $3.6M | $8.1M | $9.8M |
| Beneficio Antes de Impuestos | $12.3M | $11.9M | $18.4M | $23.6M | $16.3M | $21.2M | $52.7M | $53.9M | $73.0M | $82.5M |
| Impuestos | $4.3M | $2.6M | $4.1M | $3.9M | $2.9M | $5.3M | $10.9M | $9.0M | $14.0M | $14.2M |
| Beneficio Neto | $8.0M | $9.2M | $14.3M | $19.8M | $13.4M | $15.9M | $41.8M | $44.9M | $59.0M | $68.3M |
| BPA | $1.11 | $1.27 | $1.95 | $2.66 | $1.79 | $2.11 | $5.52 | $5.89 | $7.69 | $8.87 |
| BPA Diluido | $1.10 | $1.26 | $1.93 | $2.63 | $1.77 | $2.09 | $5.45 | $5.83 | $7.58 | $8.77 |
| Acciones en Circulación (Diluidas) | $7.3M | $7.3M | $7.4M | $7.5M | $7.6M | $7.6M | $7.7M | $7.7M | $7.8M | $7.8M |
Precio
| Precio | $275.41 |
| Capitalización | $2.1B |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: AHCO · ALVO · CNMD · ESTA · IMNM · OMCL · PGNY
Explorar sector: Healthcare · Medical - Devices
Más secciones de UFPT: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones